Abstract:
:Lemborexant (DAYVIGO™) is an orally administered, dual orexin receptor (OXR) antagonist that exhibits reversible competitive antagonism at OXR1 and OXR2 (> affinity at OXR2) that was discovered and developed by Eisai Inc. for the treatment of adult patients with insomnia. In December 2019, lemborexant received its first approval (with final interim scheduling) in the USA for the treatment of adult patients with insomnia, characterized by difficulties with sleep onset and/or sleep maintenance. In January 2020, lemborexant also received approval in Japan for the treatment of insomnia. It is also being investigated for the treatment of irregular sleep-wake rhythm disorder (ISWRD) associated with mild to moderate Alzheimer's disease. This article summarizes the milestones in the development of lemborexant leading to its first global approval.
journal_name
Drugsjournal_title
Drugsauthors
Scott LJdoi
10.1007/s40265-020-01276-1subject
Has Abstractpub_date
2020-03-01 00:00:00pages
425-432issue
4eissn
0012-6667issn
1179-1950pii
10.1007/s40265-020-01276-1journal_volume
80pub_type
杂志文章,评审相关文献
DRUGS文献大全abstract::The effect of cefotaxime and ceftriaxone on faecal flora was investigated in women undergoing routine vaginal or abdominal hysterectomy. Three groups of 9 patients received, in a double-blind fashion and just before surgery, cefotaxime 2g intravenously, ceftriaxone 2g intravenously or no antibiotic (controls). Stools ...
journal_title:Drugs
pub_type: 临床试验,杂志文章
doi:10.2165/00003495-198800352-00004
更新日期:1988-01-01 00:00:00
abstract::Clopidogrel is a thienopyridine that irreversibly inhibits platelet aggregation by selectively binding to adenylate cyclase-coupled ADP receptors on the platelet surface. In animal models, clopidogrel reduced the formation of both arterial and venous thrombi. After oral administration, clopidogrel is rapidly absorbed ...
journal_title:Drugs
pub_type: 杂志文章,评审
doi:10.2165/00003495-199754050-00006
更新日期:1997-11-01 00:00:00
abstract::The optimal treatment of pain requires an understanding of the mechanisms involved. Pain is a sensory end-point that can be generated by a number of dissimilar processes. Consequently, the concept of treating pain as a unitary symptom is obsolete. The mechanisms responsible for specific types of pain need to be unders...
journal_title:Drugs
pub_type: 杂志文章,评审
doi:10.2165/00003495-199400475-00003
更新日期:1994-01-01 00:00:00
abstract::Onychomycoses, infections of the nail caused by fungi, are amongst the most common illnesses. Because of the high incidence of these infections and problems involved in their therapy, they have received much attention, particularly as concerns a better characterisation of the causative micro-organisms. Onychomycosis c...
journal_title:Drugs
pub_type: 杂志文章,评审
doi:10.2165/00003495-199958020-00005
更新日期:1999-08-01 00:00:00
abstract::Chenodeoxycholic acid (chenic acid; CDCA) is 1 of the 3 major biliary bile acids in man. When administered in pharmacological doses it causes a decrease in cholesterol saturation of bile, which in turn may lead to gradual dissolution of cholesterol gallstones. The stone dissolution rate during CDCA therapy has varied ...
journal_title:Drugs
pub_type: 杂志文章,评审
doi:10.2165/00003495-198121020-00002
更新日期:1981-02-01 00:00:00
abstract::Enalapril provides significant haemodynamic, symptomatic and clinical improvement when added to maintenance therapy with digitalis and diuretics in patients with congestive heart failure [NYHA (New York Heart Association) classes II to IV]. These effects are not attenuated during long term therapy. More significantly,...
journal_title:Drugs
pub_type: 临床试验,杂志文章,评审
doi:10.2165/00003495-198937020-00004
更新日期:1989-02-01 00:00:00
abstract::The rationale for an arginine vasopressin (argipressin) infusion was put forward after it was discovered that patients in shock states might have an endogenous arginine vasopressin deficiency. Subsequently, several investigations impressively demonstrated that arginine vasopressin can successfully stabilise haemodynam...
journal_title:Drugs
pub_type: 杂志文章,评审
doi:10.2165/00003495-200363030-00001
更新日期:2003-01-01 00:00:00
abstract::Hairy cell leukaemia is an uncommon B cell chronic lymphoproliferative disorder characterised by circulating lymphocytes displaying prominent cytoplasmic projections. Therapy is initiated for severe cytopenias or recurrent infections. Splenectomy, the first standard treatment, is now less commonly used as primary trea...
journal_title:Drugs
pub_type: 杂志文章,评审
doi:10.2165/00003495-199549060-00006
更新日期:1995-06-01 00:00:00
abstract::The discovery of immune inhibitory checkpoints has revolutionized the approach to the systemic treatment of cancer. The programmed death 1 (PD-1) inhibitory checkpoint, in particular, has played a key role in understanding how certain cancers can evade immune surveillance. Blocking the interaction between the PD-1 rec...
journal_title:Drugs
pub_type: 杂志文章,评审
doi:10.1007/s40265-015-0376-z
更新日期:2015-04-01 00:00:00
abstract:UNLABELLED:Gatifloxacin is an 8-methoxy fluoroquinolone antibacterial agent. The drug has a broader spectrum of antibacterial activity than the older fluoroquinolones (e.g. ciprofloxacin) and shows good activity against many Gram-positive and Gram-negative pathogens, atypical organisms and some anaerobes. Notably, gati...
journal_title:Drugs
pub_type: 杂志文章,评审
doi:10.2165/00003495-200262010-00007
更新日期:2002-01-01 00:00:00
abstract::Osteoarthritis, the most common rheumatic disease, presents the clinician with a major therapeutic and management task. The chronic and progressive course of the disease is punctuated by pain, declining function and escalating disability. This article attempts to deal with the pharmacological therapeutic options avail...
journal_title:Drugs
pub_type: 杂志文章,评审
doi:10.2165/00003495-199141020-00005
更新日期:1991-02-01 00:00:00
abstract::Intravenous inotuzumab ozogamicin (Besponsa®; Pfizer) is an anti-CD22 monoclonal antibody-calicheamicin conjugate that binds to CD22-expressing tumour cells. Upon binding, the complex is internalised and the cytotoxic calicheamicin derivative is released inside the cell, inducing double-strand DNA breakage and subsequ...
journal_title:Drugs
pub_type: 杂志文章,评审
doi:10.1007/s40265-017-0802-5
更新日期:2017-09-01 00:00:00
abstract::Chronic pancreatitis is a clinical entity that results from the progressive inflammation and irreversible fibrosis of the pancreas resulting from the cumulative injury sustained by the pancreas over time. It is an illness with variable presentations that can severely impact quality of life, while its long-term complic...
journal_title:Drugs
pub_type: 杂志文章
doi:10.1007/s40265-020-01360-6
更新日期:2020-08-01 00:00:00
abstract::Irinotecan (CPT-II) is a semisynthetic derivative of camptothecin. It and other camptothecin analogues/derivatives appear to exert their antitumour activity by binding to topoisomerase I. The active metabolite of irinotecan, 7-ethyl-10-hydroxycamptothecin (SN-38), has demonstrated potent growth inhibition of human col...
journal_title:Drugs
pub_type: 杂志文章,评审
doi:10.2165/00003495-199652040-00013
更新日期:1996-10-01 00:00:00
abstract::After surgery, patients try to minimise discomfort by various manoeuvres including change of posture, immobilisation of injured areas and use of analgesic drugs. The characteristic finding with drug use, revealed by permitting patients to titrate themselves with analgesic from a machine, is that the interindividual do...
journal_title:Drugs
pub_type: 杂志文章,评审
doi:10.2165/00003495-198529040-00004
更新日期:1985-04-01 00:00:00
abstract::The efficacy and safety of cefadroxil in the treatment of paediatric patients with a wide variety of infections were evaluated in a multicentre clinical trial. This study included 395 infants and children with Group A streptococcal pharyngitis, sinusitis, otitis media, bronchitis, pneumonia or bronchopneumonia, urinar...
journal_title:Drugs
pub_type: 杂志文章
doi:10.2165/00003495-198600323-00005
更新日期:1986-01-01 00:00:00
abstract::Gastric cancer is the seventh and oesophageal cancer the ninth most common cancer in the UK, and >50% of patients present with locally advanced or metastatic disease. The incidence of oesophageal and oesophagogastric junctional tumours is increasing, making these important disease entities to understand and research. ...
journal_title:Drugs
pub_type: 杂志文章,评审
doi:10.2165/00003495-200767170-00006
更新日期:2007-01-01 00:00:00
abstract::Rapid progress has recently been encountered in pharmacologically treating the unborn baby. This unique area of drug therapy raises new methodological and ethical questions. This article is a systematic review of known modalities of fetal pharmacotherapy, and aims to highlight essential principles, difficulties and co...
journal_title:Drugs
pub_type: 杂志文章,评审
doi:10.2165/00003495-200262050-00004
更新日期:2002-01-01 00:00:00
abstract::The efficacy of tropisetron in the prevention of nausea and vomiting induced by chemotherapy of varying emetogenic potential was evaluated in 545 patients with a variety of malignancies who had either proved refractory to antiemetic treatment during previous chemotherapy courses or who were considered to be at high ri...
journal_title:Drugs
pub_type: 杂志文章
doi:10.2165/00003495-199200433-00007
更新日期:1992-01-01 00:00:00
abstract::The meningococcal groups C and Y and Haemophilus b (Hib) tetanus toxoid conjugate vaccine (HibMenCY-TT) contains Neisseria meningitidis serogroup C and Y capsular polysaccharide antigens, and Hib capsular polysaccharide [polyribosyl-ribitol-phosphate (PRP)]. The HibMenCY-TT vaccine is available in the USA for use as a...
journal_title:Drugs
pub_type: 杂志文章,评审
doi:10.1007/s40265-013-0048-9
更新日期:2013-05-01 00:00:00
abstract::Mortality and morbidity in gastroenteritis in children is the result of fluid loss, acid-base and electrolyte imbalance. Hence therapy should be aimed at preventing or correcting this imbalance. The use of intestinal antibiotics to treat the condition should not be a routine, but parenteral antibiotic therapy in the p...
journal_title:Drugs
pub_type: 杂志文章,评审
doi:10.2165/00003495-197611040-00004
更新日期:1976-01-01 00:00:00
abstract::Each antiarrhythmic agent can cause side effects, but most of these are easily recognised by the patient or physician. However, one potentially serious side effect common to all of these drugs is aggravation of ventricular arrhythmia. Often this is without symptoms and goes unrecognised by the patient. It occurs in 11...
journal_title:Drugs
pub_type: 杂志文章
doi:10.2165/00003495-198500294-00009
更新日期:1985-01-01 00:00:00
abstract::The objective of this study was to evaluate the haemodynamic and antiarrhythmic effects of flecainide acetate in patients with heart failure. Flecainide acetate, a class Ic antiarrhythmic agent, was given intravenously to 9 patients with congestive heart failure and frequent ventricular arrhythmias with nonsustained v...
journal_title:Drugs
pub_type: 杂志文章
doi:10.2165/00003495-198500294-00012
更新日期:1985-01-01 00:00:00
abstract::Alteplase is the product of recombinant DNA technology and is chemically identical to endogenous tissue-type plasminogen activator: Plasminogen is converted to plasmin by alteplase, and fibrinolysis of blood thrombi is subsequently stimulated. Alteplase is now firmly established as a treatment of choice in the managem...
journal_title:Drugs
pub_type: 杂志文章,评审
doi:10.2165/00003495-199550020-00007
更新日期:1995-08-01 00:00:00
abstract::Atherosclerosis can be defined in terms of the processes involved rather than in morphological terms, and there is evidence for possible roles of the macrophage in atherogenesis. The relevance of hyperlipidaemia to the morphogenesis of the atherosclerotic plaque is important, and this has been described in animal mode...
journal_title:Drugs
pub_type: 杂志文章,评审
doi:10.2165/00003495-198800363-00012
更新日期:1988-01-01 00:00:00
abstract::Aflibercept (Eylea(®)) is an anti-vascular endothelial growth factor agent indicated for intravitreal use in the treatment of diabetic macular oedema. In patients with diabetic macular oedema, significantly greater improvements from baseline to week 52 in visual acuity were seen with intravitreal aflibercept versus ma...
journal_title:Drugs
pub_type: 杂志文章,评审
doi:10.1007/s40265-015-0421-y
更新日期:2015-07-01 00:00:00
abstract::Brodalumab (Lumicef(®)) is a human monoclonal immunoglobulin G antibody that is being developed by Kyowa Hakko Kirin in Japan, where it has been approved for the treatment of psoriasis vulgaris, psoriatic arthritis, pustular psoriasis and psoriatic erythroderma. Brodalumab binds with high affinity to interleukin (IL)-...
journal_title:Drugs
pub_type: 杂志文章
doi:10.1007/s40265-016-0634-8
更新日期:2016-09-01 00:00:00
abstract::The use of digitalis in congestive heart failure with normal sinus rhythm is still debated. While older uncontrolled, withdrawal studies from 1969 to 1983 provided incomplete data, with poorly documented clinical status and poor haemodynamic and exercise data, some patients did improve clinically when digitalis treatm...
journal_title:Drugs
pub_type: 杂志文章,评审
doi:10.2165/00003495-199855060-00002
更新日期:1998-06-01 00:00:00
abstract::Opioid dependence, manifesting as addiction to heroin and pharmaceutical opioids is increasing. Internationally, there are an estimated 15.6 million illicit opioid users. The global economic burden of opioid dependence is profound both in terms of HIV and hepatitis C virus transmission, direct healthcare costs, and in...
journal_title:Drugs
pub_type: 杂志文章,评审
doi:10.2165/11597520-000000000-00000
更新日期:2012-01-22 00:00:00
abstract::The proton pump inhibitors (PPIs) are the most successful class of drugs that have been introduced for the treatment of gastro-oesophageal reflux disease (GORD) because of their profound and consistent effect on gastric acid secretion. The PPIs have demonstrated an excellent adverse effect profile after approximately ...
journal_title:Drugs
pub_type: 杂志文章,评审
doi:10.2165/00003495-200464030-00004
更新日期:2004-01-01 00:00:00